logo
  

Voip-Pal.com Reveals Voluntary Lock-Up Agreement With Largest Shareholder

Voip-Pal.com Inc. (VPLM.PK) announced Wednesday that it has entered into a voluntary Lock-Up Agreement with its largest shareholder, Emil Malak.

Malak was a co-founder of Digifonica Intellectual Properties Limited, which was acquired by Voip-Pal in 2013. He received over 350 million restricted shares of Voip-Pal stock for the acquisition of Digifonica, representing about 40% of the company.

Voip-Pal.Com, which owns a portfolio of patents relating to Voice-over-Internet Protocol or VoIP technology, noted that those shares are now eligible to become free trading.

According to the firm, the voluntary lock-up agreement restricts the sale of those shares until the successful monetization of Voip-Pal's technology. Malak currently serves as an advisor to the Board of Directors.

Thomas Sawyer, Chairman and CEO of Voip-Pal stated, "It is gratifying to the Board and Management to have our largest shareholder so firmly confident in the future of Voip-Pal.com that he would voluntarily extend the Rule 144 restriction on his shares."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the third quarter on Friday, consumer goods giant Procter & Gamble Co. (PG) raised its earnings per share and core net earnings per share growth guidance for the full-year 2024, while maintaining its annual all-in sales growth outlook. For fiscal 2024, the company... Sony Pictures Entertainment, affiliated to Japanese conglomerate Sony Group Corp., is in discussions with US private equity group Apollo Global for making a joint takeover bid for entertainment giant Paramount Global, reports said citing people familiar with the matter. The talks are said to be in an early stage. Following the news, Paramount Global shares were gaining around 10.7 percent... Newport Beach, California - based Sammy's Milk has warned parents against the use of its Goat Milk Toddler Formula as an infant formula, as asked by the U.S. Food and Drug Administration or FDA. The company notes that the product is specifically formulated for children between the ages of 12 and 36 months, and not for infants under 12 months of age.

Inflation data from the U.S. garnered maximum attention this week on the economics front, along with the interest rate decision by the European Central Bank. Read our stories to find out how these two key events are set to influence monetary policy in the months ahead. Other main news from the U.S. were the release of the minutes of the latest Fed policy session and the jobless claims data. Elsewhere, the interest rate decision by the Bank of Canada was also in focus.

View More Videos
Follow RTT